Jaklenec Group's News

October 31, 2023

Vaccines provide substantial safety against infectious diseases, saving millions of lives each year. However, the delivery of vaccines imposes a unique set of challenges due to their large molecular size and low room temperature stability...

October 27, 2023

Vitamin A deficiency impacts millions globally. Directly adding it to foods is problematic due to its sensitivity to light and heat. We've created an edible microparticle ensuring safe vitamin A delivery. These microparticles are stable and offer...

October 25, 2023

Our tabletop printer could make this and other vaccines more accessible across the globe...

October 10, 2023

Congratulations to Quanyin Hu, who was named a recipient of the 2023 Cellular and Molecular Bioengineering (CMBE) Rising Star Award for Junior Faculty. Quanyin Hu was a postdoc in the Jaklenec group from 2018-2020 and is now an...

September 28, 2023

Congratulations to Erika Wang on being named Banting Postdoctoral Fellow by the Canadian government. The highly prestigious fellowship recognizes scholars who demonstrate outstanding potential to contribute positively to Canada's economic...

July 11, 2023

Patches to the rescue! New techniques for delivering drugs and vaccines through the skin...

May 31, 2023

The Jaklenec Group's vaccine printer could help vaccines reach more people. The conversation no one else is having...

May 26, 2023

Graduate student, Linzixuan Rhoda Zhang was awarded the Controlled Release Society Trainee Award. Rhoda will present her abstract at the CRS 2023 Annual Meeting & Expo during the Oral Delivery Focus Group's session in Las Vegas in July!...

May 23, 2023

Developing a vaccine is only half the job to saving lives – distributing it can be a real challenge. Many drugs need to be kept cool and require hypodermic needles for injection – these microneedles may change that... 

May 17, 2023

Principal Research Scientist Ana Jaklenec discusses her work developing a mobile vaccine printer. The device “can be very important in certain scenarios when you’re trying to bring the ability to vaccinate in areas that might not have the right infrastructure to make vaccines or...